CABA
Cabaletta Bio Inc
2.20$
-2.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Cabaletta Bio Inc (CABA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -42 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.0 | -1.1 | -1.9 | -2.3 | -3.8 | -2.1 | -7.9 | -4.9 | -7.6 | -5.0 | -9.2 | -8.7 | -6.6 | -8.3 | -11 | -13 | -12 | -9.9 | -12 | -13 | -12 | -13 | -16 | -24 | -21 | -20 | -23 | -31 | -30 | -35 | -35 | -43 | -42 | -154 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | 4.4 | 5.4 | |
| 0.0 | 0.0 | 0.2 | 0.3 | 0.5 | 0.4 | 0.6 | 0.8 | 0.9 | 1.1 | 1.1 | 1.3 | 1.3 | 1.4 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.6 | 2.5 | 2.8 | 3.0 | 3.1 | 3.8 | 5.0 | 5.3 | 5.4 | 5.2 | 5.7 | 5.8 | 4.3 | 5.3 | 5.5 | 21 | |
| – | – | 7.6 | 3.9 | 0.5 | 0.6 | 0.6 | 0.8 | 0.9 | 1.1 | 1.2 | 1.4 | 1.3 | 1.4 | 1.5 | 1.6 | 1.8 | 1.7 | 1.7 | 4.6 | 2.5 | 3.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.6 | -0.3 | 0.8 | -0.9 | 2.0 | -3.4 | 1.6 | -0.7 | 2.1 | -1.3 | -0.4 | 3.0 | 1.5 | 1.5 | -1.8 | -0.6 | -0.5 | -1.4 | -0.1 | -1.0 | 0.5 | 0.7 | -4.1 | 0.0 | 2.9 | 2.9 | -3.0 | 4.1 | 0.2 | -1.6 | -9.4 | -0.5 | -11 | |
| 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.3 | 0.2 | 0.0 | 0.2 | 0.2 | 0.1 | 0.4 | 0.5 | 0.2 | 0.1 | 0.9 | 1.1 | 0.3 | 0.4 | 0.1 | 0.1 | 0.2 | 0.8 | 0.8 | 0.3 | 0.4 | 0.8 | 0.2 | 0.1 | 0.2 | 0.0 | 0.0 | 0.3 | |
| – | – | -0.2 | -0.2 | -0.2 | -0.2 | 0.0 | -0.3 | -0.2 | -11 | 1.5 | 1.9 | 2.4 | 1.0 | 1.8 | 0.8 | -50 | -0.9 | 24 | -0.3 | 25 | -48 | -0.1 | 1.1 | -0.8 | 24 | 12 | 12 | -0.8 | -49 | -50 | 50 | 51 | – | – | |
| – | – | – | – | – | – | – | 10 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 13 | 13 | -0.2 | -0.2 | -1.1 | 0.0 | 1.3 | 0.0 | -0.1 | – | -0.2 | 0.2 | 7.8 | 25 | 0.1 | – | – | – | 0.1 | -0.2 | – | – | 0.3 | – | – | 0.1 | 0.1 | – | – | 0.2 | 0.3 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | -0.6 | -3.0 | -0.8 | -1.9 | -4.3 | -2.8 | -9.8 | |
| 0.0 | 0.0 | 24 | 25 | 50 | -1.0 | -2.1 | 73 | 0.0 | -0.1 | 0.1 | 0.0 | 2.2 | 7.8 | 25 | 14 | 0.1 | 0.0 | 0.1 | 33 | 0.2 | 94 | 0.1 | 93 | 6.9 | 0.4 | 0.1 | 4.4 | -0.6 | 93 | -0.8 | 8.3 | 25 | 150 | 183 | |
| 0.0 | 0.0 | -1.1 | 23 | 47 | -5.0 | -4.2 | 65 | -5.2 | -19 | -3.4 | -7.3 | -4.2 | 2.2 | 19 | 4.0 | -63 | -12 | 14 | 20 | 12 | 34 | -13 | 78 | -18 | 3.3 | -8.0 | -6.6 | -32 | 14 | -85 | 23 | 34 | 108 | 79 | |
| 0.0 | 0.0 | -1.1 | -1.9 | -2.4 | -4.0 | -2.1 | -8.2 | -5.2 | -7.7 | -5.2 | -9.4 | -8.8 | -7.0 | -8.9 | -11 | -13 | -12 | -11 | -12 | -13 | -12 | -13 | -17 | -25 | -22 | -21 | -23 | -32 | -31 | -35 | -36 | -43 | -42 | -154 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.